Starting HIV treatment with a CD4 cell count below 350 cells/mm3 may increase the long-term risk of cardiovascular disease, US research published in AIDS suggests. Investigators found that men who started therapy with a CD4 cell count below this threshold had much poorer endothelial function, a key measure of vascular health, than individuals who started treatment when their CD4 cell count was above 350 cells/mm3.
Please click here for the full article.
www.aegis.org